Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.410
+0.100 (2.32%)
Oct 31, 2025, 4:00 PM EDT - Market closed

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $7.56M in the quarter ending June 30, 2025, with 9.71% growth. This brings the company's revenue in the last twelve months to $24.17M, down -31.30% year-over-year. In the year 2024, Foghorn Therapeutics had annual revenue of $22.60M, down -33.83%.

Revenue (ttm)
$24.17M
Revenue Growth
-31.30%
P/S Ratio
11.47
Revenue / Employee
$215,830
Employees
112
Market Cap
249.30M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings

FHTX News

More News